Larvol Delta - CellCentric-Initiates-DOMMINO1-a-Pivotal-Phase-2-Clinical-Trial-of-Inobrodib-in-Combination-with-Pomalidomide-and-Dexamethasone-InoPd-in-Relapsed-or-Refractory-Multiple-Myeloma

inobrodib (CCS1477) - CellCentric

https://www.businesswire.com/news/home/20260331718599/en/CellCentric-Initiates-DOMMINO-1-a-Pivotal-Phase-2-Clinical-Trial-of-Inobrodib-in-Combination-with-Pomalidomide-and-Dexamethasone-InoPd-in-Relapsed-or-Refractory-Multiple-Myeloma

Mar 31, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next